Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Kroger (KR) downgraded to Neutral from Buy at Cleveland Research with analyst Scott Bender saying he believes there is more potential risk than upside to consensus earnings estimates over the next 6-12 months given persistent retail deflation and an intensifying competitive environment. 2. Medivation (MDVN) downgraded to Hold from Buy at Stifel, to Neutral from Outperform at Credit Suisse, to Neutral from Buy at SunTrust, and to Hold from Buy at Brean Capital. 3. Logitech (LOGI) downgraded to Neutral from Buy at UBS. 4. Oasis Petroleum (OAS) downgraded to Market Perform from Outperform at BMO Capital with analyst Dan McSpirit citing valuation. 5. ResMed (RMD) downgraded to Underperform from Hold at Jefferies with analyst Anthony Petrone noting that the firm's survey and expert calls indicate that those in the field see the company's AirSense10 as still "best-in-class," but Philips' (PHG) Dream has closed the gap while being priced at a discount. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

VP of Kroger, Mary Ellen Adcock, disclosed the sale of 82,806 shares of company stock at $55.61 per share on April 23, for a total transaction amount of $4,605,189.

Attorney General Bob Ferguson announced he signed onto a pending resolution with Kroger that will bring in $47.5M to combat the opioid epidemic in Washington state. Half of these resources will go to the state and the other half will go to Washington city and county governments. The $47.5M will be paid over 11 years. The first payment of $4.3M will come within a few months of the resolution being finalized by the litigating states and local jurisdictions, Ferguson said in a statement.

JPMorgan analyst Ken Goldman added Albertsons (ACI) to the firm's Analyst Focus List as a value idea and placed the stock on "Positive Catalyst Watch" following the fiscal Q4 earnings release. The "gap between the current share price and fair value is too wide," the analyst tells investors in a research note. The firm says its trimming of out-year estimates does not impair Albertsons' standalone value, which it estimates at $24 per share. JPMorgan continues to believe the stock's valuation discount to Kroger (KR) is too wide given the companies similarities. It also believes the probability that Albertsons gets bought has increased, given yesterday's announcement that additional stores and services will be sent C&S's way. The firm says the risk/reward for Albertsons stock "is becoming too appealing to ignore." It keeps an Overweight rating on the name with a $27 price target.